Brief: Appili Therapeutics Signs $3M Grant Contract With The United States Department Of Defense To Develop Antibiotics That Target Superbugs
02/07/2019 12:21
July 2 (Reuters) - Appili Therapeutics Inc APLI.V :
* APPILI THERAPEUTICS SIGNS $3M USD GRANT CONTRACT WITH THE
UNITED
STATES DEPARTMENT OF DEFENSE TO DEVELOP ANTIBIOTICS THAT TARGET
SUPERBUGS
* APPILI THERAPEUTICS INC - WILL USE FUNDS TO CONTINUE
ADVANCING
ITS ATI-1503 ANTIBIOTIC PROGRAM
Source text for Eikon: ID:nBwyQ666a
Further company coverage: APLI.V
(Reuters.Briefs@thomsonreuters.com)
Recent news on Appili Therapeutics
See all newsBrief: Appili Therapeutics Announces Closing Of Second Tranche Of Non-Brokered Private Placement
Brief: Appili Therapeutics Closes First Tranche Of Non-Brokered Private Placement
Brief: Appili Therapeutics Announces Proposed Non-Brokered Private Placement
Brief: Appili Therapeutics Announces Formal Termination Of Arrangement Agreement With Aditxt
Brief: Appili Therapeutics Announces New Patents Granted For Commercial Stage Asset Likmez